method of Merrifield (7) with the aid ofan automated peptide synthesizer (990; Beckman Instruments, Inc ., Palo Alto, CA) . The peptides were purified by gel filtration and reverse-phase HPLC (8) . Amino acid composition of each peptide was confirmed by use of an automatic amino acid analyzer (121 MB; Beckman Instruments, Inc.) (9) .
Isolation and Culture of Peripheral Blood Monocytes. Blood taken by venipuncture from healthy human volunteers was collected in heparinized syringes and centrifuged on Ficoll-Hypaque cushions to obtain a population of mononuclear leukocytes (MNL), as previously described (10) . After washing in RPMI 1640 containing fresh L-glutamine, penicillin (100 U/ML), and streptomycin (100 pg/ml) (Gibco Laboratories), a monocyte-enriched population was obtained by subjecting the MNL to centrifugal elutriation, as previously described (11). To obtain highly purified monocyte populations ofcells, elutriated MNL were labeled with M02-R01 (monocyte-specific PE conjugate) and KC56-FITC (T 200 Ag) (pan leukocyte marker) (Coulter Cyto-Stat ; Coulter Immunology, Hialeah, FL) and sorted as previously described (12) .
To generate supernatants containing products from activated monocytes, elutriated monocytes (4 x 106 cells) and sorted monocytes (6 x 101) were placed in separate wells of 24-well 3424 Mark II Cluster Dishes (Costar, Cambridge, MA), each in 1 ml ofserumfree RPMI 1640 containing streptomycin (100 l g/ml), penicillin (100 U/ml), fresh L-glutamine (300 pg/ml), and 100 ng/ml LPS W from Escherichia coli 055 :BB (Difco Laboratories, Inc ., Detroit, MI) . Monocytes were cultured for 48 h at 37°C in an incubator with a humidified atmosphere containing 5% CO2 . Culture supernatants were harvested, clarified by centrifugation, and stored at -70°C for up to 4 d before study.
Results
Chemotaxis ofFibroblasts to hrTNF-a. On a total of three occasions when wide ranges of concentrations of hrTNF-a were studied, maximal migration of fibroblasts was consistently induced by concentrations of hrTNF-a ranging from 50 to 900 pg/ml (1.39-25 pM) . A representative dose-response curve is presented in Fig. 1 . The response curve was always dose dependent and bell shaped . Similar bell-shaped response curves have been previously reported with other fibroblast chemoattractants (2, 3) . To assess whether TNF-a was inducing migration of fibroblasts by acting as a chemokinetic or chemotactic agent, a Zigmond-Hirsch checkerboard anal- 
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Tumor Necrosis Factor a-induced Fibroblast Chemotaxis ysis was performed . TNF-a caused migration of fibroblasts only when it was present in excess in the lower compartment of the chemotaxis chambers, indicating that it acts as a chemotactic agent (Table 1) . Similar results were obtained when this experiment was repeated (data not shown) .
Inhibition of TNF-a-induced Chemotaxis by AntiTNF-a Antibodies. To assess the effect of anti-hrTNF-a antibodies on the ability of hrTNF-a to induce fibroblast chemotaxis, hrTNF-a or TGF-01 (an unrelated chemotactic cytokine) were incubated for 12 h at 4°C with polyclonal rabbit anti-hrTNF-a or antiTGF-01 antibodies, or with anti-hrTNF-ca mAb. There was marked inhibition of the chemotactic response of fibroblasts to TNF-a when it was preincubated with polyclonal anti-hrTNF-a antiserum or with anti-hrTNF-a mAb, but no inhibition ofchemotaxis was observed when TNF-ca was treated with antiTGF-(31 IgG ( Table 2 ) . The anti-hrTNF-a antiserum and anti-hrTNF-ca mAb did not reduce the chemotactic response of fibroblasts to TGF-(31, indicating that their effect was not through a general suppression of the chemotactic responsiveness of fibroblasts ( Table 2) . Chemotaxis of Fibroblasts to FMLP. It has been suggested that the chemotactic activity for neutrophils and monocytes reported with some preparations of hrTNF-a derived from E. coli might be due to small amounts of contaminating N-formylated methionyl peptides or N-formylated methionylhrTNF-a (13). Therefore, it was of interest to explore the possible role of N-formylated compounds in mediating the fibroblast chemotactic response to hrTNF-ac. FMLP is a prototype of bacteria-derived N-formylmethionyl chemotactic peptides that have been studied extensively in neutrophils and monocytes (14, 15) . Therefore, the ability of FMLP to induced fibroblast migration was assessed . In a total of three dose-response experiments performed, FMLP induced fibroblast migration at 10 fM to 10 pM. A representative dose- response curve is plotted in Fig. 2 . Zigmond-Hirsch checkerboard analysis indicated that this migration was predominantly chemotactic in nature since most migration occurred when FMLP was present in excess in the lower compartment of the Chmotaxis chambers (Table 3) . Similar results were observed when this experiment was repeated (data not shown) .
On neutrophils, there appears to be a single class of receptor that recognizes most formylated methionyl peptides, and FMLP can compete for binding of synthetic and bacteriaderived chemotactic formylated methionyl peptides to this class ofreceptor (14, 15). Ifthere were formylated methionyl peptides in the hrTNF-a preparation, these neutrophil-related data would imply that it should be possible to block their chemotactic effect on fibroblasts by allowing FMLP to be present in the upper cell compartment of the Chmotaxis chambers when the Chmotaxis assay is performed . When FMLP was added to the upper compartment of Chmotaxis chambers containing fibroblasts, it could not block the migration to hrTNF-a, but it did block the response to FMLP (Table 4 ). These findings, although indirect, suggest that the chemotactic response offibroblasts to hrTNF-ca is not mediated through a receptor recognized by or a mechanism related to FMLP. Chemotaxis ofFbbmblasts to Synthetic TNF-a 31-68. In an effort to localize the region of the TNF-a molecule involved in the fibroblast chemotactic response, synthetic peptides were made representing all but the first nine amino acids ofhuman TNF-a, and tested for their ability to induce fibroblast migra-tion (Fig. 3 ). Peptides were repeatedly tested over a wide concentration range for their ability to induce fibroblast migration. Only one peptide, TNF-a 31-68, induced fibroblast migration (Fig. 4) . The response curve, like that ofhrTNF-a, was bell shaped (Fig. 4) . Zigmond-Hirsch checkerboard analysis indicated that this active peptide induced mostly chemotactic migration of fibroblasts (Table 5) . A small amount of chemokinetic activity was repeatedly observed at intermediate concentrations of the peptide (Table 5) . To assess the rela- tionship of the chemotactic response of fibroblasts to TNF-a 31-68 and hrTNF-a, we repeatedly performed experiments in which the fibroblasts in the upper cell compartment of the chemotaxis chambers were suspended in either media, hrTNF-a, or TNF-a 31-68, and compared the migration of variously treated fibroblasts to hrTNF-a, TNF-a 31-68, TGF-01, and media. Results of a typical experiment are shown in Table 6 . HfNF-a and TNF-a 31-68 were equally effective in blocking the migration of fibroblasts to each other, but neither blocked the response to TGF-f1 (Table 6 ) . These data suggest that hrTNF-a and TNF-a 31-68 induce fibroblast migration through either a common receptor or mechanism. Neutralization by AntiTNRa mAb ofFibroblast Chemotactic Actitriry in Supernatants from Cultures ofHuman Monocytes Stimulated by LPS. Since monocytes/macrophages are potential sources of several fibroblast chemoattractants (e.g ., TGFO-1, fibronectin, leukotriene B4, platelet-derived growth factor [PDGF]), it was important to determine the relative portion of fibroblasts chemotactic activity in cultures of stimulated human peripheral blood monocytes attributable to TNF-a. To assess this, peripheral blood monocytes purified by centrifugal elutriation or centrifugal elutriation and FRCS were stimulated for 24-48 h by LPS, and the harvested supernatants, after treatment with antiTNF-a mAb or PBS as a control, were tested at various dilutions for fibroblast chemotactic activity. Supernatant from cultures of elutriated monocytes stimulated with LPS elicited maximal chemotactic response of fibroblasts at a 1:80 dilution (Fig . 5 A) . The chemotactic activity at this and other dilutions of the supernatant was almost totally neutralized by anti-hrTNF-a mAb (Fig. 5 A) . Supernatants from elutriated and sorted monocytes stimulated with LPS induced fibroblast migration at 1:20, 1:40, and 1:80 dilutions (Fig . 5 B) . Anti-hrTNF-a mAb neutralized most of the fibroblast chemotactic activity in the supernatant at these dilutions (Fig. 5 B) . These data suggest that Figure 3 . Peptides representing the deduced human TNF-a sequence were synthesized by the solid-phase method of Merrifield (7) on an automated peptide synthesizer (990; Beckman Instruments, Inc.) (8) . (*)This peptide was synthesized without residues 1-9 . It has been previously demonstrated that NHZ-terminal residues are not essential for TNF-a activity (19). TNF-a is the major fibroblast chemoattractant produced by peripheral blood monocytes under these experimental conditions.
Discussion
HrTNF-a is a potent chemotactic agent for fibroblasts in vitro inducing their migration at picomolar concentrations. The TNF-at fibroblast chemotactic dose-response curve is bell shaped . This type dose-response curve has been previously observed with several different fibroblast chemotactic agents and with FMLP in this present study (2) (3) (4) . A synthetic peptide representing the TNF-ca amino acid sequence 31-68 also induced chemotaxis of fibroblasts. TNF-a 31-68 was much less potent than hrTNF-a in inducing chemotaxis. A similar reduction of potency has been reported with synthetic peptides of growth hormone and of human IL10 (16-18) . The reduced potency ofTNF-a 31-68 relative to hrTNF-(x is likely Table 5 . Effect of Varying Concentration Gradients of TNF-a Peptide 31-68 on Fibroblast Migration alues " Fibroblasts were suspended in complete serum-free maintenance media with or without hrTNF-a (29.4 pM) or TNF-a 31-68 (164 nM) and added to the upper compartment of chemotaxis chambers . Migration of fibroblasts to hrTNF-a, TNF-a 31-68, TGF-S1, or media was then quantitated. Values represent the mean t SEM of quadruplicate values. t The chemotactic activities obtained when the lower compartment of chemotaxis chambers contained each chemoattractant or media and the upper compartment of the chambers contained fibroblasts suspended in hrTNF-a or TNF-a 31-68 were each compared by the two-sample student's t test with the values generated in chambers containing fibroblasts suspended in media. S Fibroblasts per 20 OIF.
Different concentrations of synthetic TNF-ci 31-68 were added to the upper and/or lower compartments of chemotaxis chambers, and the number of fibroblasts miograting to the lower surface of each filter was quantitated. Each value represents the mean of four replicates ± SEM of fibroblasts per 20 01F. " The number of fibroblasts migrating when the peptide was present in a given chemotaxis chamber at the same concentration in the upper and lower compartments. due to its small size and lack of other amino acid sequences necessary for binding to TNF-a receptors or for conferring secondary, tertiary, and quaternary structural features for optimal interaction with fibroblasts . The finding that a synthetic peptide of TNF-a composed of residues 31-68 has a biologic activity of the parent TNF-a molecule is of special interest since a particularly conserved region of human TNF-a occurs in amino acids 35-66 . This region shares 50% amino acid homology with human lymphotoxin (6) . X-ray crystallographic analyses indicate that TNF-a forms a trimer with residues near the COON and NH2 termini, being located at the base of the trimer and likely involved in receptor binding (19). A pocket lined by highly conserved (between human TNF-a and lymphotoxin) sequences 11-13, 37-42, 49-57, and 155-157 may be critically involved in binding of TNF-a and lymphotoxin to its receptor (19). We have not yet assessed the ability of TNF-a 31-68 or the remaining TNF-a peptides used in this study to compete with hrTNF-ci binding to its receptor.
Although FMLP was also found to be a potent fibroblast chemoattractant in the present study, several different lines of evidence suggest that trace or low concentrations of N-formylmethionyl peptides are not involved in the chemotactic response of fibroblasts to the hrTNF-a preparations tested . First, mAb to hrTNF-ci selectively blocked the chemotactic response of fibroblasts to hrTNF-a but not to TGF-ail . This argues against trace contaminants of N-formylmethionyl peptides in the hrTNF-a preparations being responsible for the fibroblast chemotactic response . Second, a synthetic peptide consisting of TFN-a residues 31-68 is itself chemotactic for fibroblasts and can selectively inhibit the migration of fibroblasts to hrTNF-a and vice versa, suggesting both the peptide and hrTNF-a induce fibroblast chemotaxis through a similar mechanism(s) . Finally, FMLP, a prototype peptide for N-formylmethionyl chemoattractants that should block the chemotactic response of fibroblasts to N-formylmethionyl peptides, does not block the chemotactic response of fibroblasts to hrTNF-a .
Other fibroblast functions have been reported to be affected by TNF-a in vitro, including stimulation of growth and synthesis of collagenase, hyaluronic acid, prostaglandin E2 , and 11, 6 (20-23) . TNF inhibits collagen gene transcription and collagen synthesis by fibroblasts (24) . Synthesis of IIAa and -10, and HLA-A,B mRNAs, are increased by TNF-ci, as is surface expression of HLA A,B antigens by fibroblasts (25, 26) . Studies are being performed to assess the effect of the synthetic TNF-a peptides used in this study on these fibroblast functions as well as their ability to lyse L cell targets .
Under certain culture conditions, monocytes/macrophages have been shown to produce several fibroblast chemoattractants (i.e., TGF-01, fibronectin, PDGF, and LTB4) . Our data suggest that TNF-a is the major biologically active fibroblast chemoattractant produced during short-term culture of peripheral blood monocytes stimulated by LPS. The fact that most of the fibroblast chemotactic activity produced by LPSstimulated monocytes in short-term culture is TNF-a may be due to the following. (a) TGF-91 is secreted by monocytes/macrophages as a latent molecule bound to an acid-labile binding protein that blocks its biologic activity (27, 28) . (b) Fibronectin is synthesized by macrophages in long-term culture (4-10 d) and not during short-term culture (29) . (c) Most (up to 80%) of PDGF secreted by macrophages is bound to acid labile proteins (mostly a2-macroglobulin) and, like TGF-(31, require acidification for expression of biologic and receptor binding activity (30) . (d) Macrophages do not synthesize LTB4 in response to LPS stimulation (31) .
TNF-a is synthesized by a variety of different macrophages, including those of pulmonary, hepatic, bone marrow, and peritoneal origins, and perhaps by T lymphocytes, mast cells, smooth muscle cells, and NK cells under certain circumstances (see reference 32 for review) . Macrophages produce TNF-ci after exposure to many different stimuli, including LPS, some Gram-positive organisms, lysates o£ certain parasites, and Sendai and influenza viruses (see reference 32 for review) . When hrTNF-a is daily injected subcutaneously into laboratory animals, it induces an acute inflammatory response that is followed by chronic inflammation, accumulation of fibroblasts, and fibrosis (33) . This present study suggests that TNF-a is a major monocyte/macrophage-derived product that may
